Newman Lisa A
Department of Surgery, Breast Care Center, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Dr, 3308 Cancer Center, Ann Arbor, MI 48109-0932, USA.
J Natl Cancer Inst Monogr. 2010;2010(41):152-7. doi: 10.1093/jncimonographs/lgq018.
Ductal carcinoma in situ (DCIS) is a disease whose manifestations are largely confined to in-breast pathology. Management strategies therefore focus on various combinations of local therapy: mastectomy, lumpectomy alone, and lumpectomy followed by breast irradiation. Although DCIS does not carry an inherent risk of distant organ metastasis, optimal local control is essential because any in-breast or chest wall recurrence may occur as an invasive lesion. Local recurrence has been reported following breast-conserving surgery as well as mastectomy. Breast radiation is therefore generally recommended following breast-conserving surgery, and in selected circumstances, mastectomy may be the preferred treatment strategy. This article reviews the surgical and associated clinicopathologic issues related to initial biopsy and perioperative planning that should be considered for all DCIS cases to optimize local control.
导管原位癌(DCIS)是一种其表现主要局限于乳腺内病理变化的疾病。因此,治疗策略集中于局部治疗的各种组合:乳房切除术、单纯肿块切除术以及肿块切除术后进行乳房放疗。虽然DCIS本身不存在远处器官转移的风险,但最佳的局部控制至关重要,因为任何乳腺内或胸壁复发都可能以浸润性病变的形式出现。保乳手术以及乳房切除术后均有局部复发的报道。因此,一般建议在保乳手术后进行乳房放疗,在某些特定情况下,乳房切除术可能是首选的治疗策略。本文回顾了与初始活检及围手术期规划相关的外科及相关临床病理问题,所有DCIS病例都应考虑这些问题以优化局部控制。